You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diabetes - Niclosamide - Diabetic kidney disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Nephropathies, Diabetes, Type 2, Chronic Kidney Diseases Trial in Milwaukee (Individualized basic need navigation and

Recruiting
  • Diabetic Nephropathies
  • +3 more
  • Individualized basic need navigation and lifestyle coaching and skills training
  • Enhanced usual care
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Aug 24, 2022

Chronic Kidney Diseases, Diabetes, Type 2, Diabetes, Type 1 Trial in Jacksonville, Rochester (Allogeneic adipose-derived

Recruiting
  • Chronic Kidney Diseases
  • +4 more
  • Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion
  • Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions
  • Jacksonville, Florida
  • +1 more
Nov 9, 2022

High Incidence of Thrombotic Events in Patients With MN and DKD

Active, not recruiting
  • Glomerulonephritis, Membranous
  • +3 more
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Dec 7, 2022

Diabetic Nephropathies Trial in Mansoura (Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine)

Recruiting
  • Diabetic Nephropathies
  • Valsartan 80 mg
  • +2 more
  • Mansoura, Egypt
    Mansoura University
Nov 28, 2022

Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes, Type 2 Trial in Rochester (Autologous adipose-derived mesenchymal

Recruiting
  • Diabetic Kidney Disease
  • +7 more
  • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
  • Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 11, 2022

Diabetes, Diabetic Kidney Disease, Hypertension Trial (Salt-Diet and/or Ertugliflozin)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Salt-Diet and/or Ertugliflozin
  • (no location specified)
Feb 3, 2023

Prevalence of Chronic Kidney Disease in Tunisian Diabetics

Recruiting
  • Chronic Kidney Diseases
  • +2 more
    • Tunis, Tunisia
      Tunisian Society for Nephrology, Dialysis and Renal Transplantat
    Jan 13, 2023

    Diabetic Kidney Disease Trial (INV-202, Placebo)

    Not yet recruiting
    • Diabetic Kidney Disease
    • (no location specified)
    Aug 22, 2022

    Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

    Recruiting
    • Diabetic Nephropathies
    • Boston, Massachusetts
    • +1 more
    Aug 15, 2022

    Disease Burden of Diabetic Patients Based on Tianjin Regional

    Completed
    • Diabetes
      • Chengdu, China
        Chengdu Big Data Association
      Jul 14, 2022

      Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

      Recruiting
      • Diabetic Kidney Disease
      • Liverpool, New South Wales, Australia
      • +6 more
      May 17, 2022

      Diabetes Mellitius Trial (Neutrophil Gelatinase and Kidney Injury Molecule-1)

      Not yet recruiting
      • Diabetes Mellitius
      • Neutrophil Gelatinase and Kidney Injury Molecule-1
      • (no location specified)
      Sep 4, 2023

      Diabetic Kidney Disease Trial in Beijing (SPH3127+SPH3127matching +valsartan matching , SPH3127+valsartan matching , SPH3127

      Not yet recruiting
      • Diabetic Kidney Disease
      • SPH3127+SPH3127matching placebo+valsartan matching placebo
      • +2 more
      • Beijing, China
        Peking Union Medical College Hospital
      Jan 9, 2023

      Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

      Active, not recruiting
      • Diabetic Nephropathy
      • Grouping based on previous laboratory results, no intervention.
      • Jinan, Shandong, China
        Qianfoshan Hospital
      Nov 8, 2023

      Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,

      Recruiting
      • Diabetic Kidney Disease
      • ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
      • Herlev, Denmark
        Department of Nephrology, Herlev and Gentofte Hospital
      May 31, 2023

      Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)

      Not yet recruiting
      • Diabetic Kidney Disease
      • IgA Nephropathy
      • Placebo of SC0062
      • +3 more
      • (no location specified)
      Jan 9, 2023

      Diabetic Foot, Diabetes, Peripheral Arterial Disease Trial in Düsseldorf (percutaneous transluminal angioplasty)

      Not yet recruiting
      • Diabetic Foot
      • +8 more
      • percutaneous transluminal angioplasty
      • Düsseldorf, Germany
        University-Hospital Düsseldorf Division of Cardiology, Pulmonary
      Nov 8, 2023

      Diabetic Kidney Disease Trial in Taichung City (Probiotic group, Placebo group)

      Not yet recruiting
      • Diabetic Kidney Disease
      • Probiotic group
      • Placebo group
      • Taichung City, Taiwan
        Chung Shan Medical University Hospital
      Dec 29, 2022

      Diabetic Foot, Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown Trial in Atlanta (device, other, behavioral)

      Not yet recruiting
      • Diabetic Foot
      • Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown
      • Real Time Continuous Glucose Monitoring (rt-CGM)
      • +2 more
      • Atlanta, Georgia
        Grady Health System
      Sep 19, 2023

      Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Renal Autologous Cell Therapy (REACT®))

      Completed
      • Type 2 Diabetes Mellitus
      • Chronic Kidney Disease
      • Renal Autologous Cell Therapy (REACT)
      • Tucson, Arizona
      • +3 more
      Jan 6, 2023

      Chronic Kidney Disease, Diabetes, Type 2, Hypertension Trial in Genova (Dapagliflozin 10mg Tab, Placebo)

      Recruiting
      • Chronic Kidney Disease
      • +2 more
      • Dapagliflozin 10mg Tab
      • Placebo
      • Genova, GE, Italy
        IRCCS Ospedale Policlinico San Martino
      Aug 10, 2023

      Chronic Kidney Diseases, Bone Diseases, Metabolic Trial in Mansoura (Dapagliflozin 10mg Tab, Placebo)

      Active, not recruiting
      • Chronic Kidney Diseases
      • Bone Diseases, Metabolic
      • Dapagliflozin 10mg Tab
      • Placebo
      • Mansoura, Aldakahliya, Egypt
        Urology and Nephrology center, Mansoura University
      Feb 16, 2023

      Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

      Recruiting
      • Diabetes Mellitus
      • Diabetic Kidney Disease
      • Sha Tin, Hong Kong
        Prince of Wales Hospital
      Nov 8, 2022

      Control of Renal Oxygen Consumption, Mitochondrial Dysfunction,

      Active, not recruiting
      • Diabetic Kidney Disease
      • +10 more
      • Aminohippurate Sodium Inj 20%
      • +3 more
      • Aurora, Colorado
        Children's Hospital Colorado
      Jul 19, 2022

      End Stage Kidney Disease Trial in Atlanta, Decatur (Continuous glucose monitoring (CGM))

      Recruiting
      • End Stage Kidney Disease
      • Continuous glucose monitoring (CGM)
      • Atlanta, Georgia
      • +3 more
      Feb 14, 2023